Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in Idiopathic Pulmonary Fibrosis (MUSIC OL)
NCT01346930Phase 2Withdrawn
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of macitentan in idiopathic pulmonary fibrosis (IPF), sponsored by Actelion Pharmaceuticals Ltd. Planned start Jul 2011; status: withdrawn.
02
Drugs
macitentan
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT01346930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346930.